Speaker(s): 

Juliann Savatt, MS, CGC-has nothing to disclose

Miranda Hallquist, MSc, CGC-has nothing to disclose

Rachel Schwiter, MGC, CGC-has nothing to disclose

Learning Objectives:

At the conclusion of this session, the participant should be able to: 

• Examine MyCode GSC work assessing penetrance and variable expressivity
• Discuss MyCode GSC results return workflow in anticipation of 2025 result
  • Recognize clinician and patient results resources and new efforts to support patients in completing recommended care
  • Describe new efforts to support patients in completing recommended care
  • Summarize why MyCode is not a replacement for clinical genetic testing through case examples

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Cara McCormick, MPH; Adam Buchanan, MS, MPH, LCGC; Juliann Savatt, MS, LCGC; Melissa Kelly, MS, LCGC and Marc Williams, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant.